Study Conduct

ClinEdge launches PatientEngage to connect patients with enrolling trials

Monday, June 27, 2016

ClinEdge Engage, a full-service patient recruitment and retention division of ClinEdge, announced the launch of PatientEngage, an active patient community and clinical trial matching service. PatientEngage is a new online platform that uses machine-learning algorithms, social media engagement, and patient advocacy networks to match eligible patients nationwide with currently enrolling clinical trials.

[Read More]

BlueTheory rebrands to BTC Network, launches new business model

Monday, June 27, 2016

BlueTheory Clinical Trials, a clinical research network company headquartered in Boston, Massachusetts has been partnering with pharmaceutical and CROs to bring treatments and devices to the market since its inception. Based on increased demands from BlueTheory’s over 30 aligned pharmaceutical and CRO strategic partners, BlueTheory has enhanced its site business model and is announcing its rebrand to BTC Network.

[Read More]

PFS Clinical, Velos partner on clinical trial management

Friday, June 24, 2016

PFS Clinical, a division of PharmaSeek, has partnered with Velos to deliver a turn-key solution that enables research institutions to better manage their clinical trials. The pairing of Velos’ industry-leading clinical trial management system (CTMS) with PFS Clinical’s team of clinical trial administration experts provides the foundation to drive operational efficiencies, improve performance, alleviate financial risk and enhance process consistency in today’s quality-driven clinical research industry.

[Read More]

CenterWatch joins WIRB-Copernicus Group

Wednesday, June 22, 2016

WIRB-Copernicus Group (WCG), one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced its acquisition of CenterWatch, the leading provider of clinical trial industry news and information, and the addition of Kenneth A. Getz, CenterWatch founder and owner, to its board of directors.

[Read More]